domingo, 9 de junio de 2019

'Anchoring' was at work in setting the price of Zolgensma - STAT

'Anchoring' was at work in setting the price of Zolgensma - STAT

First Opinion

‘Anchoring’ was at work in setting the price of Novartis’ new gene therapy

By PETER B. BACH


ADOBE
In the U.S., drugs are priced at what the market will bear. A concept known as anchoring helped prime us for the $2.1 million price tag for Zolgensma.

No hay comentarios: